Commun Dis Rep CDR Rev. 1993 Sep 10;3(10):R135-9.
Hepatitis C virus (HCV) transmission after percutaneous exposure to blood at work has been documented. Follow up of health care workers who report significant percutaneous or mucocutaneous exposures to sources that are known to be, or that might be, HCV-infected should include storage of serum from the source (if identifiable) and anti-HCV testing of the blood specimen obtained from the health care worker at six months post-exposure. Routine testing of the health care worker's initial post-exposure specimen for anti-HCV is not recommended at present, nor is the routine use of human normal immunoglobulin as prophylaxis against HCV infection. Routine anti-HCV testing of blood specimens obtained from identifiable sources of unknown HCV status is not at present justified.
工作中经皮接触血液后丙型肝炎病毒（HCV）传播已有记录。对报告有重大经皮或黏膜接触已知或可能感染HCV来源的医护人员进行随访，应包括储存来源血清（如可识别），并在接触后6个月对医护人员采集的血液标本进行抗HCV检测。目前不建议对医护人员接触后的初始标本进行常规抗HCV检测，也不建议常规使用人正常免疫球蛋白预防HCV感染。目前对来自HCV状态不明的可识别来源的血液标本进行常规抗HCV检测尚无正当理由。
